Work

In a 68-year-old woman with hypertension at high risk for cardiovascular disease, is the combination of Telmisartan and Ramipril more effective in controlling hypertension and reducing cardiovascular risk than either drug alone?

Year: 2026
Type: article
Abstract: No direct evidence for the combination of Telmisartan and Ramipril over monotherapy in controlling hypertension and reducing cardiovascular risk was found; combination therapy does not show additional cardiovascular benefits and may increase renal risk.
Author: Tripdatabase
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236852133
FWCI:
Cites:
Cited by:
Related to: 10